tiprankstipranks
Lyra Therapeutics (LYRA)
NASDAQ:LYRA
US Market

Lyra Therapeutics (LYRA) Technical Analysis

Compare
289 Followers

Technical Sentiment

Overall Consensus
Neutral
11Bullish
2Neutral
9Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Lyra Therapeutics’s (LYRA) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Lyra Therapeutics is a Sell.
Lyra Therapeutics’s (LYRA) 20-Day exponential moving average is 0.19, while Lyra Therapeutics’s (LYRA) share price is $0.21, making it a Buy.
Lyra Therapeutics’s (LYRA) 50-Day exponential moving average is 0.20, while Lyra Therapeutics’s (LYRA) share price is $0.21, making it a Buy.

Lyra Therapeutics (LYRA) Pivot Points

Feb 17, 2025, 12:09 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.17
0.18
0.20
0.21
0.22
0.23
0.25
Fibonacci
0.18
0.19
0.20
0.21
0.22
0.22
0.23
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lyra Therapeutics (LYRA) Moving Averages

Feb 17, 2025, 12:09 AM
Period
Simple
Exponential
MA5
0.20Buy
0.20Buy
MA10
0.19Buy
0.20Buy
MA20
0.19Buy
0.19Buy
MA50
0.19Buy
0.20Buy
MA100
0.21Sell
0.36Sell
MA200
0.35Sell
1.09Sell
Lyra Therapeutics’s (LYRA) 10-Day exponential moving average is 0.20, while Lyra Therapeutics’s (LYRA) share price is $0.21, making it a Buy.
Lyra Therapeutics’s (LYRA) 100-Day exponential moving average is 0.36, while Lyra Therapeutics’s (LYRA) share price is $0.21, making it a Sell.
Lyra Therapeutics’s (LYRA) stock price is $0.21 and Lyra Therapeutics’s (LYRA) 50-day simple moving average is 0.19, creating a Buy signal.
Lyra Therapeutics’s (LYRA) stock price is $0.21 and Lyra Therapeutics’s (LYRA) 100-day simple moving average is 0.21, creating a Sell signal.
Lyra Therapeutics’s (LYRA) stock price is $0.21 and Lyra Therapeutics’s (LYRA) 200-day simple moving average is 0.35, creating a Sell signal.

Lyra Therapeutics (LYRA) Technical Indicators

Feb 17, 2025, 12:09 AM
Name
Value
Implied Action
RSI (14)
67.08
Neutral
STOCH (9,6)
80.22
Sell
STOCHRSI (14)
81.15
Sell
MACD (12,26)
<0.01
Sell
ADX (14)
17.43
Buy
Williams %R
-18.60
Sell
CCI (14)
228.78
Sell
ATR (14)
0.02
-
Ultimate Oscillator
53.26
Neutral
ROC
10.53
Buy
Lyra Therapeutics’s (LYRA) Relative Strength Index (RSI) is 67.08, creating a Neutral signal.
Lyra Therapeutics’s (LYRA) Trend Strength Indicator (ADX) is 17.43, creating a Buy signal.
Lyra Therapeutics’s (LYRA) Commodity Channel Index (CCI) is 228.78, creating a Sell signal.
Lyra Therapeutics’s (LYRA) Price Rate of Change (ROC) is 10.53, creating a Buy signal.

FAQ

Is LYRA a Buy, Hold, or Sell?
Based on LYRA’s technical indicators, LYRA is a Hold.
    What is LYRA’s RSI (14)?
    LYRA’s RSI (14) is 67.08, which suggests LYRA is a Neutral.
      What is LYRA’s MACD?
      LYRA’s MACD is <0.01, which suggests LYRA is a Sell.
        What is LYRA’s 5-day moving average?
        LYRA’s 5-day moving average is 0.20, which suggests LYRA is a Buy.
          What is LYRA’s 20-day moving average?
          LYRA 20-day moving average is 0.19, which suggests LYRA is a Buy.
            What is LYRA’s 50-day moving average?
            LYRA’s 50-day moving average is 0.19, which suggests LYRA is a Buy.
              What is LYRA’s 200-day moving average?
              LYRA’s 200-day moving average is 0.35, which suggests LYRA is a Sell.
                What is LYRA’s Williams % R (14)?
                LYRA’s Williams % R (14) is -18.60, which suggests LYRA is a Sell.
                  What is LYRA’s CCI (14)?
                  LYRA’s CCI (14) is 228.78, which suggests LYRA is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis